Rare diseases
Investigational molecules
Locations
Back to Italy16 clinical trials in Bagno A Ripoli, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
ItalyMaintenance Therapy Study of Inavolisib with Pertuzumab and Trastuzumab in Patients with HER2‑Positive, PIK3CA‑Mutated Locally Advanced or Metastatic Breast Cancer
ItalyStudy on Colchicine and Aspirin for Improving Heart Health in Adults with Type 2 Diabetes Without Previous Heart Events
ItalyStudy of Vemurafenib, Cobimetinib, and Atezolizumab for Patients with High-Risk, Surgically Removable BRAF Mutated and Wild-Type Melanoma
ItalyItalyStudy on XyloCore and Drug Combination for Patients with End-Stage Kidney Disease Undergoing Peritoneal Dialysis
ItalyStudy on Regorafenib for Patients with Recurrent Grade 2 and 3 Meningioma After Surgery and Radiotherapy
ItalyStudy on Tranexamic Acid and Sodium Chloride for Patients with Stroke-Related Brain Bleeding
ItalyOsimertinib and drug combination in metastatic non‑small cell lung cancer with targetable genomic driver alterations
ItalyStudy on Corticosteroids, Dapagliflozin, and Drug Combination for Proteinuria in IgA Nephropathy Patients with Active or Chronic Kidney Lesions
ItalyStudy of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease
ItalyStudy on Early Switching to Dolutegravir and Lamivudine for Adults with HIV-1 on Three-Drug Regimen with Virological Suppression
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative research exploring two-drug regimens for HIV-1 treatment, focusing on effectiveness of early switching strategies in virologically suppressed patients.
These trials aim to simplify treatment while maintaining optimal viral control.
Studies investigating cardiovascular outcomes in type 2 diabetes patients, exploring preventive strategies using established medications in new combinations.
Focus on preventing adverse cardiovascular events in high-risk populations.
Advanced research in breast cancer and melanoma treatment, evaluating targeted therapies and comparing treatment approaches.
Emphasis on personalized treatment strategies for different cancer types.
Innovative studies in end-stage kidney disease treatment, testing new dialysis solutions and cardiovascular outcomes.
Focus on improving dialysis outcomes and patient quality of life.
Critical investigations into SARS-CoV-2 treatment options, evaluating novel therapeutic approaches for varying disease severities.
Emphasis on developing effective treatment protocols for different patient populations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
